Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for SWDCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
March 31, 2026 2.72%
December 31, 2025 2.40%
September 30, 2025 3.11%
June 30, 2025 -1.07%
March 31, 2025 3.73%
December 31, 2024 3.60%
September 30, 2024 3.74%
June 30, 2024 3.31%
March 31, 2024 5.04%
December 31, 2023 -2.07%
September 30, 2023 6.33%
June 30, 2023 2.85%
March 31, 2023 3.29%
December 31, 2022 3.17%
September 30, 2022 0.79%
June 30, 2022 12.78%
March 31, 2022 3.89%
December 31, 2021 7.71%
September 30, 2021 4.88%
June 30, 2021 9.50%
March 31, 2021 6.66%
December 31, 2020 7.34%
September 30, 2020 20.84%
Date Value
June 30, 2020 16.07%
March 31, 2020 22.37%
December 31, 2019 16.79%
September 30, 2019 27.95%
June 30, 2019 22.42%
March 31, 2019 27.85%
December 31, 2018 20.67%
September 30, 2018 29.00%
June 30, 2018 22.66%
March 31, 2018 22.14%
December 31, 2017 22.78%
September 30, 2017 20.68%
June 30, 2017 11.75%
March 31, 2017 22.85%
December 31, 2016 4.00%
September 30, 2016 24.10%
June 30, 2016 23.61%
March 31, 2016 23.95%
December 31, 2015 -5.71%
September 30, 2015 31.81%
June 30, 2015 34.49%
March 31, 2015 28.81%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Orexo AB -2.10K%
Camurus AB 26.98%
Moberg Pharma AB -25.66%
Infant Bacterial Therapeutics AB --
AstraZeneca PLC 20.15%